Two molecular pathways to transitional cell carcinoma of the bladder.
about
Understanding the development of human bladder cancer by using a whole-organ genomic mapping strategyMolecular substratification of bladder cancer: moving towards individualized patient managementNew and contemporary markers of prognosis in nonmuscle invasive urothelial cancerMolecular genesis of non-muscle-invasive urothelial carcinoma (NMIUC)Personalized medicine in advanced urothelial cancer: when to treat, how to treat and who to treat.Molecular markers in transitional cell carcinoma of the bladder: New insights into mechanisms and prognosisOvercoming cellular senescence in human cancer pathogenesisBioinformatic identification of FGF, p38-MAPK, and calcium signalling pathways associated with carcinoma in situ in the urinary bladder.Effects of the kava chalcone flavokawain A differ in bladder cancer cells with wild-type versus mutant p53.Phosphorylated p70S6K in noninvasive low-grade urothelial carcinoma of the bladder: correlation with tumor recurrence.Biopsies of the normal-appearing urothelium in primary bladder cancer.Genetic variations in the sonic hedgehog pathway affect clinical outcomes in non-muscle-invasive bladder cancerUnique DNA methylation patterns distinguish noninvasive and invasive urothelial cancers and establish an epigenetic field defect in premalignant tissueCellular origin of bladder neoplasia and tissue dynamics of its progression to invasive carcinomaA meta-analysis of the relationship between FGFR3 and TP53 mutations in bladder cancer.Identification of Apo-A1 as a biomarker for early diagnosis of bladder transitional cell carcinomaGenomic instability in complicated and uncomplicated Egyptian schistosomiasis haematobium patientsDefining a 0.5-mb region of genomic gain on chromosome 6p22 in bladder cancer by quantitative-multiplex polymerase chain reactionAqueous Extract of Shi-Liu-Wei-Liu-Qi-Yin Induces G2/M Phase Arrest and Apoptosis in Human Bladder Carcinoma Cells via Fas and Mitochondrial PathwayPrevalence and spectrum of microsatellite alterations in nonmuscle invasive bladder cancers.Prognostic Significance of CREB-Binding Protein and CD81 Expression in Primary High Grade Non-Muscle Invasive Bladder Cancer: Identification of Novel Biomarkers for Bladder Cancer Using Antibody Microarray.Immunohistochemistry and Fluorescence In Situ Hybridization Can Inform the Differential Diagnosis of Low-Grade Noninvasive Urothelial Carcinoma with an Inverted Growth Pattern and Inverted Urothelial Papilloma.Patterns of chromosomal imbalances in advanced urinary bladder cancer detected by comparative genomic hybridizationFrequent genetic alterations in simple urothelial hyperplasias of the bladder in patients with papillary urothelial carcinoma.Urinary bladder transitional cell carcinogenesis is associated with down-regulation of NF1 tumor suppressor gene in vivo and in vitro.FEZ1/LZTS1 is down-regulated in high-grade bladder cancer, and its restoration suppresses tumorigenicity in transitional cell carcinoma cells.Detection of chromosomal imbalances in transitional cell carcinoma of the bladder by comparative genomic hybridization.Bracken fern-induced bladder tumors in guinea pigs. A model for human neoplasia.Frequent FGFR3 mutations in papillary non-invasive bladder (pTa) tumorsEpigenetic alterations in bladder cancer and their potential clinical implications.Effects of P-MAPA Immunomodulator on Toll-Like Receptors and p53: Potential Therapeutic Strategies for Infectious Diseases and CancerFibroblast growth factor receptor 3 mutations in bladder tumors correlate with low frequency of chromosome alterations.Loss of heterozygosity on chromosomes 11 and 17 are markers of recurrence in TCC of the bladder.A population-based study of immunohistochemical detection of p53 alteration in bladder cancer.p53-stabilizing agent CP-31398 prevents growth and invasion of urothelial cancer of the bladder in transgenic UPII-SV40T mice.Chromosomal imbalance in the progression of high-risk non-muscle invasive bladder cancer.Cystatin B as a tissue and urinary biomarker of bladder cancer recurrence and disease progression.Metformin represses bladder cancer progression by inhibiting stem cell repopulation via COX2/PGE2/STAT3 axis.Expression profile of SPACA5/Spaca5 in spermatogenesis and transitional cell carcinoma of the bladder.Kava chalcone, flavokawain A, inhibits urothelial tumorigenesis in the UPII-SV40T transgenic mouse model.
P2860
Q24604540-A829ED17-2511-4615-B1D5-FED464EB2D3BQ26744343-944D2EAC-B33C-4578-BB42-0FD2ADBEE020Q26798006-5CEA0F8B-FD32-4CF0-856E-EF13AC28A318Q30433431-CB21ABAC-DA4D-4201-BF41-C0385E9C667FQ30437629-FEEB0B17-4172-43D2-93B0-A559A8572C26Q30439612-075CE470-1ABB-420F-B7A0-D4D96B24557BQ30448767-8B0002FF-0D40-4A62-9242-0ED793F1FDDBQ33317632-7EDC5F76-021D-4724-ACAF-9D544D638C0BQ33697172-1764563C-D472-4CE5-A573-DDD54D601E23Q33922437-AE7443F2-8358-4B19-A4D6-E04A669C82C5Q34146737-9A9BAF79-39A3-4A8D-8386-6568F4FC36A4Q34203675-27EBA06D-096B-47FA-9933-164E813CA0E2Q34203924-F00EB902-6469-44AA-A82C-6A77506298A9Q34338401-A111A159-2133-40A8-B64F-ADE21CBA5C85Q34524813-3CE2B2C3-BF2C-4470-B016-6273306E68A3Q34950660-8EC6BE9D-4FD2-49F2-8E61-92DA11AFEE12Q35016365-55A9A5FB-391F-46FA-9691-1A613186A18AQ35083274-5C00EC94-84A6-4E43-9F32-B92F7044A99DQ35102010-01875A23-24CF-4B53-A8A0-58ADE5CAE9C1Q35298090-94FE9149-E181-4C12-A739-DEC9B8CA663DQ35542497-AA3157FC-86F2-4D78-B554-58FF3ACDE562Q35712039-4155A74C-B6C7-40C9-8AE5-8BE5D99C1CCAQ35754504-23A00FA1-6CF4-4FCE-9D91-A3BE88BBC187Q35786216-70E6D4F7-D758-465E-A9FB-8491629BF0FEQ35786303-33C4CEA0-058C-48BA-968E-6E006716E4EBQ35788955-7E247EC4-9908-4032-94FA-7697E5E51BDDQ35798145-4C8C7A88-AD58-4E6C-AF8D-44FBBEDDF80CQ35798430-2B2F275B-D9D4-4F0E-A690-44955D2770BDQ35842206-D9AC7585-0F6B-4FDF-B105-1338E0DB9AE8Q36095721-A0CE5878-2402-4F54-A346-100E39E0719DQ36127825-CBDE6649-D239-4E41-9DF4-11A0454B63AEQ36405463-F1FE4851-A19A-4E47-8CFD-232711E3ADD3Q36623394-6A35D71E-1D86-4CD6-993A-DB4D71E7C83AQ36695023-BC5D6AF7-57E2-474B-A01E-01AE0F03F333Q37061038-CE7C94C7-4DF7-4E04-93B8-5B1ACED8A233Q37227743-DB139C73-2F50-4C00-8EAE-ED9060E60D75Q37308146-3F2E9595-CA9C-4039-AE1F-A4FE1393CDCCQ37317523-E1A21A06-EF45-4F92-9999-D1195B9BF660Q37407149-BA3383D9-E518-484B-91CE-F7BE16FABE24Q37416331-511EF212-C6C4-4EF3-A323-8F6C7EA4260D
P2860
Two molecular pathways to transitional cell carcinoma of the bladder.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh-hant
name
Two molecular pathways to transitional cell carcinoma of the bladder.
@en
Two molecular pathways to transitional cell carcinoma of the bladder.
@nl
type
label
Two molecular pathways to transitional cell carcinoma of the bladder.
@en
Two molecular pathways to transitional cell carcinoma of the bladder.
@nl
prefLabel
Two molecular pathways to transitional cell carcinoma of the bladder.
@en
Two molecular pathways to transitional cell carcinoma of the bladder.
@nl
P2093
P1433
P1476
Two molecular pathways to transitional cell carcinoma of the bladder.
@en
P2093
Gonzalez-Zulueta M
Ohneseit PF
Schmütte C
Spruck CH 3rd
P304
P407
P577
1994-02-01T00:00:00Z